0161 446 3664
BA, DPhil (Oxon), MBBS, MRCP (Diabetes and Endocrinology)
Started at The Christie (Year)
At The Christie
Clinical lead for:
- DXA and metabolic bone service
- Long term Endocrine complications of cancer treatment
- Turner Syndrome service
- Growth Hormone service
- Pituitary/General Endocrinology
- Joint Transition Clinic with Paediatric Oncology
- Joint Late Effects Clinic with Oncology
At other sites
- Endocrine Consultant Wythenshawe Hospital: General Endocrinology
- Visiting Fellow University of Derby
- Honorary Senior Lecturer University of Manchester
- NIHR CRN Greater Manchester specialty lead: Endocrinology, Metabolism and Lipids
Dr Claire Higham undertook a physiology degree and DPhil at Merton College, Oxford followed by completion of her medical training at Royal Free/University College London.
Her junior doctor training was in London followed by higher specialist training in Manchester including a 3 year clinical research fellowship at The Christie. Dr Higham became an endocrine consultant at The Christie in 2012.
Medical Research Council- CARP (Clinical Academic Research Partnership) Award Holder 2019: Bone Toxicity Following Pelvic Radiotherapy
- Visiting Fellow at University of Derby: DXA reporting for clinicians module
- Member of Royal Osteoporosis Society BDTAP (Bone Densitometry and Assessment Panel)
- Co-lead for Masters Module “Living With and Beyond Cancer” in conjunction with The Christie School of Oncology and University of Manchester
- Publications in The Christie research publications repository
- Higham CE, Thomas JDJ, Bidlingmaier M, Drake WM, Trainer PJ. Successful use of weekly pegvisomant administration in patients with acromegaly. Eur J Endocrinol. 2009 161(1):21–5.
- Higham CE, Trainer PJ. Growth hormone excess and the development of growth hormone receptor antagonists. Exp Physiol. 2008 93(11):1157–69.
- Higham CE, Hull RL, Lawrie L, Shennan KI, Morris JF, Birch NP, et al. Processing of synthetic pro-islet amyloid polypeptide (proIAPP) “amylin” by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro. Eur J Biochem 2000 267:4998–5004.
- Higham CE, Jaikaran ET, Fraser PE, Gross M, Clark A. Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils. FEBS Lett 2000 470:55–60.
The Christie Private Care
Dr Higham also practises privately at The Christie Private Care
- Contact: 0161 446 3664
- Email: email@example.com